附 录
(一)附图
A. 未输入 GSE accession 时的提示消息。B. 未选择 matrix 文件时的提示消息。C. 选择了错误的 matrix 文件时的提示消息。D. 未选择 SOFT 文件时的提示消息。E. 选择了错误的 SOFT 文件时的提示消息。E. 输入了错误的 HUGO 基因符号(只有一个基因)时的提示消息。F. 输入了错误的 HUGO 基因符号(有多个基因)时的提示消息。
A. PI3K_AKT_MTOR_SIGNALING
(上)和 TNFA_SIGNALING_VIA_NFKB
(上),作为 MTORC1_SIGNALING
的对照。B. UV_RESPONSE_UP
(上)和UV_RESPONSE_DN
(下),作为 DNA_REPAIR
的对照。C. PROTEIN_SECRETION
(上)和 APOPTOSIS
(下),作为 UNFOLDED_PROTEIN_RESPONSE
的对照。基因集名称均省略前缀 HALLMARK_
。
A. 离散型表型。B. 先折叠数据集,然后以特定基因的表达量作为表型,图中演示了搜索基因符号的功能(这里是部分匹配)。
(二)附表
集合 | 基因集 | N | n |
---|---|---|---|
c1 | CHR12Q24 |
102 | 35 |
c2.cgp | HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY |
89 | 33 |
c3.tft | E2F_Q3_01 |
72 | 30 |
c2.cgp | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN |
85 | 29 |
c2.cgp | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C |
86 | 29 |
c3.tft | E2F_Q4_01 |
72 | 29 |
c2.cgp | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 |
81 | 28 |
c3.tft | E2F_Q4 |
73 | 28 |
c3.tft | E2F1_Q6 |
74 | 28 |
c3.tft | E2F1_Q4 |
71 | 28 |
c5 | GO_NUCLEAR_ENVELOPE_ORGANIZATION |
86 | 27 |
c2.cgp | NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON |
66 | 27 |
c2.cgp | ZHANG_TLX_TARGETS_36HR_DN |
85 | 27 |
c2.cgp | MITSIADES_RESPONSE_TO_APLIDIN_DN |
88 | 27 |
c3.tft | E2F1_Q6_01 |
75 | 27 |
c3.tft | E2F1_Q4_01 |
71 | 27 |
c5 | GO_NUCLEAR_PORE |
84 | 27 |
c2.cgp | MORI_IMMATURE_B_LYMPHOCYTE_DN |
88 | 27 |
c6.all | RB_P107_DN.V1_UP |
76 | 27 |
c3.tft | E2F_Q3 |
77 | 27 |
c2.cgp | PUJANA_XPRSS_INT_NETWORK |
86 | 27 |
c3.tft | E2F4DP2_01 |
74 | 27 |
c2.cgp | PUJANA_BRCA_CENTERED_NETWORK |
81 | 27 |
c3.tft | E2F1_Q3 |
72 | 27 |
c5 | GO_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION |
85 | 26 |
集合 | 基因集 | N | n |
---|---|---|---|
c1 | CHR12Q24 |
102 | 36 |
c1 | CHR12Q23 |
91 | 11 |
h | HALLMARK_MITOTIC_SPINDLE |
71 | 25 |
h | HALLMARK_G2M_CHECKPOINT |
76 | 24 |
h | HALLMARK_E2F_TARGETS |
71 | 23 |
h | HALLMARK_MYC_TARGETS_V1 |
67 | 22 |
h | HALLMARK_MYC_TARGETS_V2 |
73 | 19 |
h | HALLMARK_MTORC1_SIGNALING |
62 | 15 |
h | HALLMARK_DNA_REPAIR |
65 | 14 |
h | HALLMARK_UNFOLDED_PROTEIN_RESPONSE |
64 | 13 |
c3.tft | E2F_Q3_01 |
72 | 30 |
c3.tft | E2F_Q4_01 |
72 | 29 |
c3.tft | E2F_Q4 |
73 | 28 |
c3.tft | E2F1_Q6 |
74 | 28 |
c3.tft | E2F1_Q4 |
71 | 28 |
c3.tft | E2F1_Q6_01 |
75 | 27 |
c3.tft | E2F1_Q4_01 |
71 | 27 |
c3.tft | E2F_Q3 |
77 | 27 |
c3.tft | E2F4DP2_01 |
74 | 27 |
c3.tft | E2F1_Q3 |
72 | 27 |
集合 | 基因集 | N | n |
---|---|---|---|
h | HALLMARK_MITOTIC_SPINDLE |
71 | 25 |
h | HALLMARK_G2M_CHECKPOINT |
76 | 24 |
h | HALLMARK_E2F_TARGETS |
71 | 23 |
h | HALLMARK_MYC_TARGETS_V1 |
67 | 22 |
h | HALLMARK_MYC_TARGETS_V2 |
73 | 19 |
c1 | CHR12Q24 |
102 | 36 |
c2.cgp | HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY |
89 | 33 |
c2.cgp | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN |
85 | 30 |
c2.cgp | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C |
86 | 30 |
c2.cp.biocarta | BIOCARTA_G1_PATHWAY |
79 | 23 |
c2.cp.biocarta | BIOCARTA_G2_PATHWAY |
79 | 22 |
c2.cp.biocarta | BIOCARTA_MCM_PATHWAY |
79 | 20 |
c2.cp.kegg | KEGG_CELL_CYCLE |
87 | 24 |
c2.cp.reactome | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM |
72 | 15 |
c3.tft | E2F_Q3_01 |
72 | 30 |
c4.cm | MODULE_98 |
75 | 24 |
c4.cm | MODULE_198 |
76 | 24 |
c5 | GO_NUCLEAR_ENVELOPE_ORGANIZATION |
86 | 28 |
c5 | GO_NUCLEAR_PORE |
84 | 28 |
c6 | RB_P107_DN.V1_UP |
76 | 28 |
集合 | 基因集 | N | n |
---|---|---|---|
(2)调控细胞周期蛋白D-CDK4/6-Rb轴 | |||
c6.all | E2F1_UP.V1_UP |
78 | 23 |
(3)调控ERα信号通路 | |||
c6.all | MYC_UP.V1_UP |
67 | 14 |